2017 | 02 | 16

Vironova is together with AstraZeneca part of a drug delivery technology Industrial Research Centre which has received 75M SEK from the Swedish foundation for Strategic Research (SSF).

At Vironova we are proud about being part of this new FoRmulaEx centre that has been recognized by SSF to meet the highest international scientific standards. The FoRmulaEx centre will develop methods for efficient and robust delivery of complex, oligonucleotide drugs. Our participation is an endorsement of our leading position in enabling electron microscopy technologies that help to speed up product development and secure final product quality in the pharmaceutical industry.

News and events

Read about the latest news and events at Vironova.

  • All news
  • Inside Vironova
  • Open positions
  • Events and publications

On demand webinar

  • Title: Unmatched Viral Particle Analysis in Vaccine and Gene Therapy Development
  • Speaker: Josefina Nilsson, head of EM services & Martin Ryner, Strategic development manager
  • Watch webinar

Upcoming events 2017

Cell & Gene Therapy Europe 2017
6-7 December, Amsterdam
Booth 24

Vironova on MyNewsDesk

Follow us on MyNewsDesk and get the latest info on investor relations, events and company news.
Click here to get to our MyNewsDesk-page.

Press contact
For press enquiries, please contact

IR contact
Mohammed Homman